Clinical Trials · NCT05048719
A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 383
- Start date
- Sep 2021
- Locations
- 44 sites, 5 countries
- Primary endpoint
- Change From Baseline in HbA1c in LY3502970 as Compared to Placebo